These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 26978652)
1. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2. Vaidya H; Rumph C; Katula KS PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652 [TBL] [Abstract][Full Text] [Related]
2. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643 [TBL] [Abstract][Full Text] [Related]
3. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma. Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606 [TBL] [Abstract][Full Text] [Related]
4. Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116. Wang Z; Chen H Anticancer Res; 2010 Nov; 30(11):4537-45. PubMed ID: 21115903 [TBL] [Abstract][Full Text] [Related]
5. Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression. Yamagata K; Li X; Ikegaki S; Oneyama C; Okada M; Nishita M; Minami Y J Biol Chem; 2012 Jan; 287(2):1588-99. PubMed ID: 22128168 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation patterns suggest the involvement of DNMT3B and TET1 in osteosarcoma development. Pires SF; de Barros JS; da Costa SS; de Oliveira Scliar M; Van Helvoort Lengert A; Boldrini É; da Silva SRM; Tasic L; Vidal DO; Krepischi ACV; Maschietto M Mol Genet Genomics; 2023 May; 298(3):721-733. PubMed ID: 37020053 [TBL] [Abstract][Full Text] [Related]
7. The human receptor tyrosine kinase Axl gene--promoter characterization and regulation of constitutive expression by Sp1, Sp3 and CpG methylation. Mudduluru G; Allgayer H Biosci Rep; 2008 Jun; 28(3):161-76. PubMed ID: 18522535 [TBL] [Abstract][Full Text] [Related]
8. Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression. Deng G; Chen A; Pong E; Kim YS Oncogene; 2001 Oct; 20(48):7120-7. PubMed ID: 11704838 [TBL] [Abstract][Full Text] [Related]
9. Fas expression in metastatic osteosarcoma cells is not regulated by CpG island methylation. Huang G; Koshkina NV; Kleinerman ES Oncol Res; 2009; 18(1):31-9. PubMed ID: 19911702 [TBL] [Abstract][Full Text] [Related]
10. Methylation of the ER-alpha Promoter Is Influenced by its Ligand Estrogen in Osteosarcoma Cells SAOS-2 In Vitro. Tübel J; Kuntz L; Marthen C; Schmitt A; Wiest I; VON Eisenhart-Rothe R; Jeschke U; Burgkart R Anticancer Res; 2016 Jun; 36(6):3199-204. PubMed ID: 27272849 [TBL] [Abstract][Full Text] [Related]
11. Silencing of Wnt5a during colon cancer metastasis involves histone modifications. Li Q; Chen H Epigenetics; 2012 Jun; 7(6):551-8. PubMed ID: 22522911 [TBL] [Abstract][Full Text] [Related]
12. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a. Zhou H; Zhang M; Yuan H; Zheng W; Meng C; Zhao D Oncol Rep; 2016 Mar; 35(3):1851-8. PubMed ID: 26708300 [TBL] [Abstract][Full Text] [Related]
14. Differential regulation of the mouse and human Wnt5a alternative promoters A and B. Katula KS; Joyner-Powell NB; Hsu CC; Kuk A DNA Cell Biol; 2012 Nov; 31(11):1585-97. PubMed ID: 23046419 [TBL] [Abstract][Full Text] [Related]
15. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients. Trifa F; Karray-Chouayekh S; Jmal E; Jmaa ZB; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R Tumour Biol; 2013 Jun; 34(3):1625-33. PubMed ID: 23417837 [TBL] [Abstract][Full Text] [Related]
16. A 5'-CG-3'-rich region in the promoter of the transcriptionally frequently silenced RET protooncogene lacks methylated cytidine residues. Munnes M; Patrone G; Schmitz B; Romeo G; Doerfler W Oncogene; 1998 Nov; 17(20):2573-83. PubMed ID: 9840920 [TBL] [Abstract][Full Text] [Related]
17. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. Hantusch B; Kalt R; Krieger S; Puri C; Kerjaschki D BMC Mol Biol; 2007 Mar; 8():20. PubMed ID: 17343736 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063 [TBL] [Abstract][Full Text] [Related]
19. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications. Müller I; Wischnewski F; Pantel K; Schwarzenbach H BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761 [TBL] [Abstract][Full Text] [Related]
20. Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas. Peng D; Hu TL; Jiang A; Washington MK; Moskaluk CA; Schneider-Stock R; El-Rifai W PLoS One; 2011; 6(7):e22009. PubMed ID: 21818286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]